Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
4/5/2025
Recent Executive Moves
4/5/2025
China Biopharma Licensing Tracker, Q1 2025 (MC)
4/5/2025
China Biopharma Financing Tracker, Q1 2025 (MC)
4/1/2025
China's Pharma Industry Shows Signs of Recovery After Economic Downtur...
4/1/2025
Akeso Eyes U.S. Approval for Innovative Lung Cancer Therapy
4/1/2025
Biotheus Initiates Phase 3 Trial for BNT327/PM8002 in China
3/31/2025
CDE Solicits Comments on the Draft Technical Specification of ICH M11:...
3/31/2025
BMS's Opdivo and Yervoy Combio Approved in China
3/31/2025
Roche's Ocrevus Receives Chinese Approval for MS
3/31/2025
Merck KGaA Acquires Commercialization Rights to Abbisko's Pimicotinib
3/28/2025
TaiMed Announces Results from Phase 2a Data on Long-Acting HIV Mainten...
3/28/2025
Recent Executive Moves
3/27/2025
Big Pharma Faces Headwinds in China as Vaccine Sales Decline (PT)
3/27/2025
China to Spur Innovation through New Reimbursement List (ThePharmaLett...
3/26/2025
Merck Licenses Hengrui's Investigational Lp(a) Inhibitor HRS-5346
3/26/2025
NMPA Holds 2025 National Drug Regulatory Policy and Law Conference
3/26/2025
NMPA Issues Announcement on the Implementation of Chinese Pharmacopoei...
3/25/2025
BrightGene Initiates Phase II Head-to-Head Study of AI-Designed BGM050...
3/25/2025
Everest Announces FDA Clearance of IND Application for Tumor-Associate...
3/25/2025
Eli Lilly Launches Lilly Gateway Laboratory in Beijing to Foster Innov...
3/25/2025
Merck Group to Expand in China with Focus on AI-Powered Precision Medi...
3/25/2025
China's BMI Fund Surpasses CNY16.5 Trillion with 11% Annual Growth
3/25/2025
Expedition Therapeutics Secures Seed Funding to Bridge Chinese Innovat...
3/25/2025
Growing Awareness and Expanding Treatment Options for Sleep Disorders ...
3/25/2025
Hengrui and Elevar Face Second FDA Rejection for Liver Cancer Combo Th...
3/24/2025
Elevation Oncology to Discontinue Development of CSPC-licensed EO-3021
3/24/2025
HBM Enters into Global Strategic Deal with AstraZeneca for Next-Gen Th...
3/24/2025
AstraZeneca Announces $2.5B Investment in China
3/24/2025
CDE Seeks Public Comments on Draft ICH M11 Clinical Protocol Template
3/24/2025
Heng Ren Partners Calls for $8.9B Cash Distribution from Sinovac and ...
Page:
11
/
363
Total number of articles:
10881
:
[First]
[<<]
[9]
[10]
[11]
[12]
[13]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit